Cited by 65COVID-19 and healthcare impactsGlobal Cancer Incidence and ScreeningHealthcare Systems and Challenges

Cancer has not gone away: a primary care perspective to support a balanced approach for timely cancer diagnosis during COVID-19

Open access
Helsper, Charles W., Campbell, Christine, Emery, Jon, Neal, Richard D., Li, Li, Rubin, Greg, Weert, Henk, Vedsted, Peter +3 more·2020·European Journal of Cancer Care

Abstract

The COVID‐19 pandemic has had a profound and direct impact on the health and lives of the global population and has placed a huge burden on healthcare systems (Mayor, 2020; CDC, 2020a,b; WHO, 2020a). As the pandemic spread, many countries took drastic actions aiming to curtail the spread of the disease and to avoid overwhelming local, regional and national health care services. Much of routine health care diverted to COVID‐19; non‐COVID primary care and specialty care services were downscaled or completely halted. (Jones et al., 2020; The Lancet Oncology, 2020a; WHO, 2020a). Fear of contracting COVID‐19 also led to patient reluctance towards attending in‐person visits (CRUK, 2020; Jones et al., 2020). Consequently, timely cancer diagnosis may have been affected, with early reports suggesting that the decreased number of general practitioner (GP) consultations, combined with the minimalised capacity for non‐COVID care, may have had a serious impact on the diagnostic pathway (CRUK, 2020; Richards et al., 2020; Dinmohamed et al., 2020; EHRN, 2020; WHO, 2020a). For example, in the Netherlands, the number of new weekly diagnoses of all cancers (except skin) dropped to 73% of normal and to 39% of normal for skin cancers (Dinmohamed et al., 2020). In the United States, a data set that included 2.7 million patients from 39 health systems, showed that appointments for cervical, colon and breast cancer screening decreased by 86%–95% in March 2020 (EHRN, 2020). In Australia, despite relatively few COVID‐19 cases, anecdotal accounts suggest while overall GP consultations have not fallen dramatically, the switch to telemedicine has been associated with reduced pathology and radiology requests, reduced referrals for suspected cancer, and early evidence of reduced cancer incidence (Cunningham, 2020). In countries with organised cancer screening programmes, services were suspended or reduced in capacity, and in some cases, staff and laboratory resources pivoted to support COVID‐19 efforts (CRUK, 2020; Dinmohamed et al., 2020).

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ecc.13290

Cites

30 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Other studies have described problems of increased antimicrobial prescribing, reduced ordering of diagnostic investigations and delayed diagnosis of cancer attributed to the pandemic-related shift to remote consultations.

    “Other studies have described problems of increased antimicrobial prescribing (120), reduced ordering of diagnostic investigations (121) and delayed diagnosis of cancer (122, 123) attributed to the pandemic-related shift to remote consultations”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Velasquez, D., & Mehrotra, A. (2020). Ensuring the growth of telehealth during COVID‐19 does not exacerbate disparities in care. https://www.healthaffairs.org/do/10.1377/hblog20200505.591306/full/ · DOI

Cited by

Sorted by citations

Authors
Helsper, C. W., Campbell, C., Emery, J., Neal, R. D., Li, L., Rubin, G., Weert, H., Vedsted, P., Walter, F. M., Weller, D., & Nekhlyudov, L.
Affiliations
  • Utrecht University (NL)
  • University of Edinburgh (GB)
  • The University of Melbourne (AU)
  • University of Leeds (GB)
  • University of Virginia (US)
  • Newcastle University (GB)
  • Amsterdam Public Health (NL)
  • Aarhus University (DK)
  • University of Cambridge (GB)
  • Brigham and Women's Hospital (US)
Corresponding author
Helsper, Charles W.
Venue
European Journal of Cancer Care
Publisher
Wiley
Published
2020-07-07
Volume
29
Issue
5
Pages
e13290-e13290
ISSN
  • 0961-5423 (ISSN-L)
  • 1365-2354
OpenAlex
W3038899650
Cited by
65
References
31
Citations by year
2025: 1 · 2024: 4 · 2023: 7 · 2022: 20 · 2021: 26 · 2020: 7
FWCI
5.42
Type
journal article
Language
en
Open access
Locations
  • European Journal of Cancer Care (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (publishedVersion, other-oa)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • Pure Amsterdam UMC (submittedVersion, cc-by)
  • Apollo (University of Cambridge) (submittedVersion, cc-by-nc)
  • Apollo
Funders
Cancer Research UK (23385)
Topics
  • Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Health Professions › General Health Professions › Healthcare Systems and Challenges
Keywords
COVID-19 pandemic, cancer diagnosis, delayed diagnosis, primary care, general practitioner visits, cancer screening, telemedicine, diagnostic pathway, healthcare disruption, cancer incidence, access to cancer care
MeSH terms
Betacoronavirus, Internet Access, COVID-19, SARS-CoV-2, Health Services Accessibility, Humans, Neoplasms, Patient Education as Topic, Pneumonia, Viral, Primary Health Care, Referral and Consultation, Telemedicine, Coronavirus Infections, Healthcare Disparities, Workflow, Delayed Diagnosis, Pandemics

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review